Reviewed
Search Log
StatusReviewed
Our craft

Built around real pharmacovigilance practice.

Service Detail

Monitor literature with traceable safety decisions.

PharmaRevix performs global and local literature monitoring for adverse drug reactions, safety signals, and relevant medical literature in line with FDA, EMA, and ICH expectations.

You need routine global literature screening
You have local literature requirements in selected regions
You need auditable decisions for inspection
You need literature signals connected to case processing
See what we deliver
Deliverables

Practical outputs your team can use immediately.

Search strategy and database list

Practical, reviewable, and ready for the owner who needs to act, approve, or respond.

Screening calendar and reviewer assignment

Practical, reviewable, and ready for the owner who needs to act, approve, or respond.

Hit triage and relevance log

Practical, reviewable, and ready for the owner who needs to act, approve, or respond.

ADR and signal escalation records

Practical, reviewable, and ready for the owner who needs to act, approve, or respond.

Quality review checklist

Practical, reviewable, and ready for the owner who needs to act, approve, or respond.

Periodic evidence archive

Practical, reviewable, and ready for the owner who needs to act, approve, or respond.

Workflow

A clear sequence from assessment to handoff.

Start a scoped review
01

Assess

Define products, active substances, and search sources

02

Plan

Run scheduled literature searches and deduplication

03

Execute

Screen, assess, and escalate safety-relevant records

04

Maintain

Archive evidence and quality-review decisions

Proof Package

Every engagement leaves an evidence trail.

The work is designed for real review: authority questions, partner due diligence, quality audits, and internal leadership updates.

ADRSignalsSenior-led

Global and local literature monitoring

Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.

Search strategies aligned to product and region

Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.

Medical review of relevant hits and safety signals

Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.

Auditable documentation of decisions and exclusions

Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.

FAQ

Common questions about Literature Screening & Management.

Short answers for teams deciding whether this is the right next step.

Ask us anything
Literature screening monitors global and local sources for adverse drug reactions, safety signals, and relevant medical literature in line with FDA, EMA, and ICH expectations.
The right timing depends on product stage, target markets, and regulatory commitments. PharmaRevix usually starts with a focused review and then sets a workplan with owners, dates, and evidence expectations.
Yes. PharmaRevix can scope this as a standalone workstream or connect it with adjacent regulatory affairs, pharmacovigilance, QMS, and submission activities.
Free 30-minute consultation

Need literature screening & management support?

Talk with PharmaRevix about scope, timelines, and the cleanest next step for your market or safety obligation.